Regenerative Medicine for Parkinson’s Disease

Takao Yasuhara, Masahiro Kameda, Takashi Agari, Isao Date

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)


Regenerative medicine for Parkinson’s disease (PD) is expected to develop dramatically with the advancement of biotechnology as represented by induced pluripotent stem cells. Existing therapeutic strategy for PD consists of medication using L-DOPA, surgery such as deep brain stimulation and rehabilitation. Current treatment cannot stop the progression of the disease, although there is definite therapeutic effect. True neurorestoration is strongly desired by regenerative medicine. This review article describes the historical development of regenerative medicine for PD, with a focus on fetal nigral cell transplantation and glial cell line-derived neurotrophic factor infusion. Subsequently, the current status of regenerative medicine for PD in terms of cell therapy and gene therapy are reviewed. In the end, the future direction to realize regenerative medicine for PD is discussed.

Original languageEnglish
Pages (from-to)113-123
Number of pages11
Journalneurologia medico-chirurgica
Issue number2
Publication statusPublished - 2015


  • Cell therapy
  • Dopaminergic neuron
  • Gene therapy
  • Induced pluripotent stem cells

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology


Dive into the research topics of 'Regenerative Medicine for Parkinson’s Disease'. Together they form a unique fingerprint.

Cite this